Revive Rx LLC Dba Revive Rx Pharmacy
Revive Rx LLC Dba Revive Rx Pharmacy appears in FDA public data with 3 recalls (including 2 Class I, the most serious class), 0 510(k) clearances, 3 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0511-2024, Class I) was initiated on Apr 20, 2024. Its most recent FDA inspection ended on Feb 7, 2025 (Official Action Indicated (OAI)).
Reviewing Revive Rx LLC Dba Revive Rx Pharmacy as a supplier? Get its full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.
Summary
- Total Recalls
- 3 (2 Class I)
- 510(k) Clearances
- 0
- Inspections
- 3
- Compliance Actions
- 1
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0511-2024 | Class I | Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded… | Apr 20, 2024 |
| D-0771-2023 | Class II | Tirzepatide 10 mg/0.5 mL Sterile Solution-2 mL Vial, Rx Only, For Sub-Q Use Only, Compounded Drug… | May 11, 2023 |
| D-0648-2022 | Class I | HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial… | Feb 11, 2022 |
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 7, 2025 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3016710945 |
| May 4, 2022 | Houston, TX | Drugs | Voluntary Action Indicated (VAI) | 3016710945 |
| Aug 6, 2021 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3016710945 |